Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

CSHL Professor David Tuveson and Research Investigator Claudia Tonelli have found a way to “intercept” pancreatic cancer. By ...

Pat Gulhati, MD, PhD, discusses findings from a comprehensive analysis of genetic, immunological, and signaling pathway variations in pancreatic cancer.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it's diagnosed, it's often ...

While CRC is on the rise in people under 50, receiving colonoscopies beginning at age 45 can help decrease your risk.

Oregon Health & Science University researchers are developing a promising new blood test that could provide a way for more ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

Immunovia (IMMVF) announced additional results from the VERIFI study of its next-generation pancreatic cancer test. Immunovia’s next-generation ...